Developers in Hoboken, Oceanport launch virtual tours amid COVID-19 crisis

With the coronavirus crisis still escalating, two prominent New Jersey developers are now among those to offer virtual tours of their newly opened residential properties.

Developers hail leasing milestone at 424-unit Hoboken tower

A new 424-unit luxury apartment building on the western edge of Hoboken is now 50 percent leased, a milestone that comes less than six months after a joint venture debuted the property.

Joint venture unveils 424-unit rental project in western Hoboken (SLIDESHOW)

A development group has opened the doors to its newest project in Hoboken, a 424-unit luxury apartment building on the city’s emerging west side.

Camber, Advance sell 529,000 sq. ft. light industrial portfolio, JLL says

A joint venture has sold more than 500,000 square feet of light industrial space in Morris County, closing the deal less than two years after acquiring the four-building portfolio.

VREP, Rubenstein detail plans to integrate newly acquired Parsippany campuses

A joint venture will set out to connect two pieces of the Morris Corporate Center property in Parsippany, creating what it says is a campus that can support a tenant requirement of more than 500,000 square feet.

NKF: Rubenstein, VREP acquire 351,000 sq. ft. Parsippany complex

A joint venture has made its latest move in Morris County with the acquisition of a 351,000-square-foot, Class A office complex in Parsippany, in a sale arranged by brokers with Newmark Knight Frank.

Bijou, Intercontinental kick off latest Hoboken project

A joint venture has broken ground on a mixed-use project that will bring 424 new luxury apartments, a recreation center and a two-acre park to a swath of western Hoboken.

Global appeal: Foreign investors see new opportunity in New Jersey

As an investment opportunity, 800 Scudders Mill Road checked just about every box. A state-of-the-art, trophy office complex that was only three years old. A prime location just outside Princeton. And, perhaps most important of all, a net lease with a blue-chip, global pharmaceutical giant, Novo Nordisk Inc., with a longstanding presence in the market.